Milad Abdalla: Elevating Phlebotomy Standards – Why Order of Draw and Blood Cultures Matter
Milad Abdalla, Medical Laboratory Technologist at Al Yalayis Government Transactions Center, shared a post on LinkedIn:
“Elevating Phlebotomy Standards – Why Order of Draw and Blood Cultures Matter
Accurate diagnostics start long before the sample reaches the analyzer. The pre‑analytical phase – especially the Order of Draw and proper Blood Culture collection – remains one of the most critical determinants of result integrity.
Why It Matters?
Additive carryover can alter results, delay diagnosis, and compromise patient safety. That’s why the CLSI sequence is the global benchmark for preventing contamination and ensuring reliable outcomes.
CLSI Order of Draw (Simplified)
- Blood Cultures — Always first to maintain sterility and avoid additive interference.
- Light Blue – Citrate — Coagulation tests requiring precise 1:9 ratio.
- Serum Tubes – Red/Gold/SST — Chemistry, serology, immunology.
- Green – Heparin — STAT chemistry and blood gases.
- Lavender – EDTA — CBC, HbA1c; collected late to avoid metal chelation interference.
- Grey – Fluoride/Oxalate — Glucose and lactate; strong inhibitors, so always last.
Blood Cultures – The First Line in Infection Diagnosis
Their accuracy depends on:
- Strict aseptic technique
- Correct blood volume
- Drawing them before any other tube
Key Takeaways
- Sterility first — Blood cultures always lead the sequence.
- Prevent additive carryover — Follow CLSI strictly.
- Volume accuracy — Especially for coagulation and cultures.
- Continuous competency — Phlebotomy excellence is a global responsibility.
By mastering these fundamentals, we elevate diagnostic accuracy and strengthen patient safety across healthcare systems worldwide.”

Stay updated with Hemostasis Today.
-
Jul 13, 2026, 11:25Luisa Müller: Advancing Anticoagulation Strategies for VITT at ISTH 2026
-
Jul 13, 2026, 10:49Joshua Zeidner: Advancing Menin Inhibitor Therapy in MD Education AML-ALL US Focus 2026
-
Jul 13, 2026, 10:25Flora Peyvandi: A Practical Approach to ALT Elevation After Gene Therapy at ISTH 2026
-
Jul 13, 2026, 10:02Jessica Garcia: Where Science and Community Come Together at ISTH 2026
-
Jul 13, 2026, 09:46Fabrice Cognasse: Is There Such a Thing as the Perfect Platelet Product?
-
Jul 13, 2026, 09:42Cancer-Associated Arterial Thromboembolism: Redefining the Thrombotic Burden in Oncology
-
Jul 13, 2026, 05:59Connecting and Collaborating at ISTH 2026 – NNHF
-
Jul 13, 2026, 05:58Lara Monica: Back at ISTH – Looking Forward to Science and Reconnections!
-
Jul 13, 2026, 05:57Barbara Adams Krolak: Exciting Updates From the ISTH 2026 Regulatory Session